GenomOncology at AMP 2026
Nov 10–14, 2026 Seattle, WA ~2k attendees Website
GenomOncology brings 3 presentations to AMP 2026 in Seattle, and exhibits at Booth 2204, MR11. Its sessions centre on configurable tertiary analysis for clinical labs, including connecting long-read whole-genome sequencing to clinical genomic reporting. The company supplies clinical decision support with sequencer integration, variant annotation, trial matching and customizable reports.
| Organization | AMP 2026 Attendance |
|---|---|
GenomOncology Cleveland, OH | |
Clinical decision support for molecular pathology and oncology: sequencer integration, variant annotation, clinical trial matching and customizable reporting. | Booth Exhibiting at Booth 2204, MR11 Thu, Nov 1211:15am–7:00pmFri, Nov 139:00am–4:00pmSat, Nov 149:00am–1:30pm Workshop Wed, Nov 11 8:00am–8:50am Built for the Lab You Actually Run: A Deep Dive Into Configurable Tertiary Analysis Configurable variant interpretation software judged against real lab deployments, from curation and liquid biopsy to structured reporting. Workshop Wed, Nov 11 9:00am–9:50am Full Stack Somatic: Connecting Long-Read HiFi WGS to Clinical Genomic Reporting A containerized somatic long-read whole-genome pipeline running from raw data through variant interpretation to a clinical report. Workshop Thu, Nov 12 6:15pm–6:45pm One Platform, Every Lab: Comprehensive Tertiary Analysis that Adapts to How You Test A single platform handles somatic and germline panels together, adapting to each lab's classification rules and reporting standards. |
Instantly find 20 buyers from GenomOncology
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with the Association for Molecular Pathology. Organization details are derived from AMP’s published lists. Submit a correction